McGlynn Katherine A, London W Thomas
HREB/DCEG, National Cancer Institute, EPS-7060, 6120 Executive Boulevard, Rockville, MD 20892, USA.
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):3-23. doi: 10.1016/j.bpg.2004.10.004.
Hepatocellular carcinoma (HCC) is a major contributor to cancer incidence and mortality. There is a wide variation, however, in the global distribution of HCC. Eighty percent of the burden is borne by countries in Asia and sub-Saharan Africa. In most high-risk countries, principal risk factors include infection with hepatitis B virus and dietary exposure to aflatoxin B(1). In contrast, hepatitis C virus and alcohol consumption are more important risk factors in low-risk countries. In recent years, the incidence of HCC has decreased in some high-risk countries and increased in some low-risk countries. Reasons for both trends are not completely understood, but are likely related to public health efforts in Asia and the increase in hepatitis C virus infection in low-risk countries. Vaccination programs against hepatitis B virus will likely decrease the HCC rate even further in decades to come.
肝细胞癌(HCC)是癌症发病率和死亡率的主要促成因素。然而,HCC在全球的分布差异很大。80%的负担由亚洲和撒哈拉以南非洲国家承担。在大多数高风险国家,主要风险因素包括感染乙型肝炎病毒和饮食中接触黄曲霉毒素B(1)。相比之下,丙型肝炎病毒和饮酒在低风险国家是更重要的风险因素。近年来,一些高风险国家的HCC发病率有所下降,而一些低风险国家的发病率则有所上升。这两种趋势的原因尚未完全明了,但可能与亚洲的公共卫生努力以及低风险国家丙型肝炎病毒感染的增加有关。针对乙型肝炎病毒的疫苗接种计划可能会在未来几十年进一步降低HCC发病率。